H U Group HoldingsTSE:4544 +1.44%68 FCF Margin % is 13.88% as of Mar. 2026, which is 210% above its 10-year median of 4.48. GuruFocus rates TSE:4544 with a GF Score™ of 68/100 and a GF Value™ of 円2,771.74 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, H U Group Holdings ranks better than 66.67% on this metric.
The historical rank and industry rank for H U Group Holdings's FCF Margin % or its related term are showing as below:
TSE:4544'
s FCF Margin % Range Over the Past 10 Years
Min: -5.77 Med: 4.48 Max: 13.85
Current: 6.75
During the past 13 years, the highest FCF Margin % of H U Group Holdings was 13.85%. The lowest was -5.77%. And the median was 4.48%.
TSE:4544's FCF Margin % is ranked better than 66.67% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: -1.845
vs TSE:4544: 6.75
H U Group Holdings FCF Margin % Related Terms
H U Group Holdings FCF Margin % Historical Data
* Premium members only.
The historical data trend for H U Group Holdings's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4544 vs TMO, DHR, IDXX: FCF Margin % Comparison
For the Diagnostics & Research subindustry, H U Group Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
H U Group Holdings FCF Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, H U Group Holdings's FCF Margin % distribution charts can be found below:
* The bar in red indicates where H U Group Holdings's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
H U Group Holdings (TSE:4544) has a FCF Margin % of 13.88% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on H U Group Holdings and its competitors. This is 210% above median its historical median of 4.48. According to the industry distribution chart, H U Group Holdings ranks #68 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 33.3%.
Is H U Group Holdings' FCF Margin % too high?
H U Group Holdings' current FCF Margin % of 13.88% is 210% above median its 10-year median of 4.48. Based on the distribution chart, H U Group Holdings ranks #68 out of 204 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, H U Group Holdings has a GF Score™ of 68/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does H U Group Holdings' FCF Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, H U Group Holdings ranks #68 out of 204 companies for FCF Margin %. This puts H U Group Holdings in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Diagnostics & Research company?
A good FCF Margin % depends on the Medical Diagnostics & Research industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on H U Group Holdings and its competitors. H U Group Holdings's current FCF Margin % is 13.88%, which is 210% above median its own 10-year median of 4.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H U Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, H U Group Holdings (TSE:4544) is currently considered Modestly Overvalued. The stock's GF Value™ is 円2,771.74, compared to a current price of 円3,244.00 — trading 17% above its estimated fair value. The current FCF Margin % is 13.88%, which is 210% above median its 10-year median of 4.48. H U Group Holdings' overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For H U Group Holdings (TSE:4544), the current FCF Margin % is 13.88% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is H U Group Holdings (TSE:4544) Overvalued in 2026?
Based on GuruFocus' analysis, H U Group Holdings stock appears to be overvalued.
The current stock price of 円3,244.00 is trading 17% above its estimated GF Value™ of 円2,771.74.
GuruFocus considers H U Group Holdings to be Modestly Overvalued.
Key valuation signals for TSE:4544:
FCF Margin %: 13.88% (210% above median its 10-year median of 4.48)
GF Value™: 円2,771.74 vs. price of 円3,244.00 (17% above fair value)
No single metric tells the full story. See the TSE:4544 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
H U Group Holdings Inc operates in the healthcare field, focusing on clinical laboratory testing and reagents. The company is engaged in four main businesses. The Clinical Laboratory Testing Business receives samples taken from patients at medical institutions to test for the disease and confirm the condition of the patient's health; In Vitro Diagnostics develops, manufactures, and sells testing reagents and equipment inside and outside Japan; Sterilization & Related Services Business provides a range of medical-related services including sterilization; and Emerging New Business & Others is a new business for future growth.
68GF Score
Get the complete analysis for TSE:4544
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4544 has been successfully added to your 
